ARCHIVES

In Brief: Hammer Reappointed chairman; Wyngaarden Names Ferguson of Baylor As OMAR Director

This article is from The Cancer Letter archive.

Vol. 14 No. 31 | July 29, 1988

Download PDF Visit The Full Archive

Related Articles

Group Chairmen Reject DCT’s Agenda For Clinical Trials Review, demand Right To Select Speakers

June 30, 1978

Obama Administration, WellPoint, Face Off Over Allegation Of Coverage Recissions

April 30, 2010

In Brief: EORTC-NCI Exchange Program Invites U.S. applicants; USC Seeks Eye Melanoma Patients

December 5, 1986

Supreme Court Decision Means FTC Scrutiny As Costly Oncology Drugs Go Off-Patent

June 21, 2013

FDA News: Rule Limits Drug Pioneers To 30-Month Patent Extension

June 20, 2003

Combination Radiation/Vaccine May Benefit Some Patients

April 29, 2005